Androstenedione
規格
63-05-8CAS番号
200-554-5EC番号
(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dioneIUPAC名
C19H26O2化学式
286.4 g/mol分子量
androstenedione; Androst-4-ene-3,17-dione; 4-Androstene-3,17-dione; 63-05-8; 4-Androstenedione; Androtex; delta-4-Androstenedione; 3,17-Dioxoandrost-4-ene; SKF 2170; delta-4-Androsten-3,17-dione; DTXSID8024523; NSC 9563; delta(sup 4)-Androstene-3,17-dione; NSC-9563; (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione; CHEBI:16422; DELTA4-Androstene-3,17-dione; NSC9563; 409J2J96VR; DTXCID204523; delta 4 Androstenedione; 4 Androstene 3,17 dione; (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthrene-3,17-dione; RefChem:388799; Therapeutic Androstenedione; (1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-ene-5,14-dione; 200-554-5; Andro; Androstendione; Fecundin; 4-ANDROSTENE-3-17-DIONE; Androstenedione [JAN]; delta-(sup4)-Androsten-3,17-dione; 17-Ketotestosterone; 4-Androsten-3,17-dione; MLS000028510; .DELTA.4-Androstene-3,17-dione; Androstenedione (JAN); NCGC00023902-06; SMR000058281; (8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione; delta-4-Androstene-3,17-dione; CAS-63-05-8; androst-4-ene-3,17-dione (androstenedione); delta4-androstenedione; Androstenedione (1.0 mg/mL in Acetonitrile); HSDB 7335; EINECS 200-554-5; CHEMBL274826; adione; UNII-409J2J96VR; MFCD00003615; Androstendione degrees; 4-ANDENDION; Androsten-3,17-dione; Opera_ID_1694; Spectrum5_002059; [4-14C]-androstenedione; Epitope ID:135869; EC 200-554-5; androst-4-en-3,17-dione; ANDROSTENEDIONE [MI]; BIDD:PXR0101; D4-Androstene-3,17-dione; Lopac0_000114; SCHEMBL23272; MLS000563086; MLS002152886; ANDROSTENEDIONE [HSDB]; (4)-Androsten-3,17-dione; ANDROSTENEDIONE [VANDF]; GTPL2860; ANDROSTENEDIONE [MART.]; ANDROSTENEDIONE [WHO-DD]; SCHEMBL20483050; BDBM91713; .delta.4-Androsten-3,17-dione; Androst-4-en-3,17-dione, 2; Delta(4)-androsten-3,17-dione; Delta(4)-androstene-3,17-dione; HMS2231F18; Androstenedione, 1mg/ml in Methanol; Tox21_110893; Tox21_202269; Tox21_300579; BBL033517; c1015; LMST02020007; MSK2287-100A; STK801871; AKOS005622710; MSK2287-1000A; Tox21_110893_1; [4-14C]androst-4-ene-3,17-dione; CCG-204209; DB01536; .delta.-(sup4)-Androsten-3,17-dione; NCGC00023902-03; NCGC00023902-04; NCGC00023902-05; NCGC00023902-07; NCGC00023902-08; NCGC00023902-09; NCGC00254238-01; NCGC00259818-01; (3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-dione; AC-11042; AC-33197; Androstenedione; 3,17-Dioxo-4-andostene; FA156791; VS-12118; A0845; EU-0100114; NS00010905; TESTOSTERONE IMPURITY A [EP IMPURITY]; WLN: L E5 B666 FV OV MUTJ A1 E1; A 9630; C00280; D00051; Exemestane Impurity 5; Testosterone EP Impurity A; Q411064; SR-01000003096; SR-01000075697; Androstenedione Solution in Acetonitrile, 1000ug/mL; Androstenedione Solution in Acetonitrile, 100ug/mL; SR-01000003096-4; SR-01000075697-1; 8F5F4DCB-1164-4F2C-B4E3-3B74F684B189; 4-Androstene-3,17-dione, VETRANAL(TM), analytical standard; Androstenedione (Androst-4-ene-3,17-dione) 1.0 mg/ml in Acetonitrile; (8R,10R,13S)-10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione; 117598-81-9別名
Androstenedioneを含む製品
Hubei Goto Biopharm Co.,Ltd. sell "4-Androstenedione(4-AD)"AndrostenedioneandrostenedioneAndrostenedione4-androstene-3,17-dioneHubei Goto Biopharm Co.,Ltd. sell "4-Androstenedione(4-AD),1,4-Androstadienedione(ADD),Bisnoralcohol(BA),9a-Hydroxy-4-androstenedione(9a-OHAD), DHEA, 17a-hydroxyprogesterone,Prednisolone, Canrenone,Progesterone, Testosterone series, Nandrolone series,"
